Volume 21, Issue 4 (Vol.21, No.4, Winter 2026)
irje 2026, 21(4): 321-335 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Gholamiveis R, Heydarpour F, Moradinazar M. Analysis of Incidence and Mortality Trends of Prostate Cancer in Iran Using Age, Period, and Cohort Approach. irje 2026; 21 (4) :321-335
URL: http://irje.tums.ac.ir/article-1-7528-en.html
URL: http://irje.tums.ac.ir/article-1-7528-en.html
1- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Associate Professor of Epidemiology, Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran ,m.moradinazar@gmail.com
2- Associate Professor of Epidemiology, Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran ,
Abstract: (38 Views)
Background and Objectives: Prostate cancer is one of the most common cancers among Iranian men and has shown a marked increase in both incidence and mortality over recent decades. This study aimed to analyze temporal trends in prostate cancer incidence and mortality in Iran using an Age–Period–Cohort (APC) analytical framework.
Methods: Data were extracted from the Global Burden of Disease Study 2021 for Iranian males aged 45 years and older during 1992–2021. Data were stratified into eight 5-year age groups and six 5-year time periods. APC analysis was conducted using the second-order difference method, and Joinpoint regression was employed to assess temporal trends in risk factors.
Results: In 2021, the age-standardized incidence rate reached 30.05 per 100,000 population, and the mortality rate reached 10.66 per 100,000 representing increases of 105.96% and 14.99%, respectively, compared to 1992. Age effects were positively associated with both incidence and mortality. The period effect peaked during 2002–2006. Cohort analysis revealed that younger birth cohorts exhibited a slower acceleration in incidence rates. Among risk factors, the disease burden attributable to smoking increased by 17.1%, while the protective effects of low calcium intake and low milk consumption diminished over time.
Conclusion: Rising incidence and mortality are shaped by age, period, and cohort effects. The relative decline in younger cohorts underscores the need for targeted prostate cancer screening programs. Strengthening public health education policies and improving access to diagnostic services can reduce the disease burden.
Methods: Data were extracted from the Global Burden of Disease Study 2021 for Iranian males aged 45 years and older during 1992–2021. Data were stratified into eight 5-year age groups and six 5-year time periods. APC analysis was conducted using the second-order difference method, and Joinpoint regression was employed to assess temporal trends in risk factors.
Results: In 2021, the age-standardized incidence rate reached 30.05 per 100,000 population, and the mortality rate reached 10.66 per 100,000 representing increases of 105.96% and 14.99%, respectively, compared to 1992. Age effects were positively associated with both incidence and mortality. The period effect peaked during 2002–2006. Cohort analysis revealed that younger birth cohorts exhibited a slower acceleration in incidence rates. Among risk factors, the disease burden attributable to smoking increased by 17.1%, while the protective effects of low calcium intake and low milk consumption diminished over time.
Conclusion: Rising incidence and mortality are shaped by age, period, and cohort effects. The relative decline in younger cohorts underscores the need for targeted prostate cancer screening programs. Strengthening public health education policies and improving access to diagnostic services can reduce the disease burden.
Keywords: Prostate cancer, Incidence, Mortality, Age–period–cohort analysis, Iran, Global burden of disease
Type of Study: Research |
Subject:
Epidemiology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
